Welcome to Ncardia,
Stop by for a chat: Booth #1452
Ncardia is a stem cell drug discovery and development company. We develop and deliver state of the art integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates. Our services are based on fully functional and validated human iPSC-derived cell models that are manufactured under strict quality assurance. Our novel Pluricyte3 Manufacturing Platform enables early implementation of hiPSC models in drug discovery.